Recent Advances in the Development of Small-molecule CCR5 Inhibitors for HIV

被引：11
|
作者：
Liu, Tao [1 ]
Weng, Zhiyong [1 ]
Dong, Xiaowu [1 ]
Hu, Yongzhou [1 ]
机构：
[1] Zhejiang Univ, Coll Pharmaceut Sci, ZJU ENS Joint Lab Med Chem, Hangzhou 310058, Zhejiang, Peoples R China
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2010年 / 10卷 / 13期
关键词：
HIV; Entry; Co-receptor; CCR5; Small-molecule inhibitor; Maraviroc; IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR ANTAGONISTS; INFECTION IN-VITRO; BIOLOGICAL EVALUATION; ANTI-HIV-1; AGENTS; HIGHLY POTENT; ANTIVIRAL ACTIVITY; ENTRY INHIBITORS; VIRAL ENTRY; PART;
D O I：
10.2174/13895575110091277
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
CCR5 (C-C chemokine receptor type 5) is a chemokine receptor that has been identified as a major HIV coreceptor in viral entry and therefore is a highly validated target for the development of new anti-HIV drugs. Here, we discuss the insights gained so far relevant to the development of small-molecule CCR5 inhibitors for the treatment of HIV, and highlight small-molecule CCR5 inhibitors that are currently under preclinical and clinical trials.
引用
收藏
页码：1277 / 1292
页数：16
相关论文
共 50 条
  • [1] Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors
    Kazmierski, W
    Bifulco, N
    Yang, HB
    Boone, L
    DeAnda, F
    Watson, C
    Kenakin, T
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (13) : 2663 - 2676
  • [2] Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists
    Kondru, Rama
    Zhang, Jun
    Ji, Changhua
    Mirzadegan, Tara
    Rotstein, David
    Sankuratri, Surya
    Dioszegi, Marianna
    MOLECULAR PHARMACOLOGY, 2008, 73 (03) : 789 - 800
  • [3] Mapping the ligand-binding site on CCR5 for small-molecule inhibitors of HIV entry.
    Seibert, C
    Sakmar, TP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U5 - U5
  • [4] Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists
    Palani, Anandan
    Tagat, Jayaram R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (10) : 2851 - 2857
  • [5] Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists
    Henrich, Timothy J.
    Lewine, Nicolas R. P.
    Lee, Sun-Hee
    Rao, Suhas S. P.
    Berro, Reem
    Gulick, Roy M.
    Moore, John P.
    Tsibris, Athe M. N.
    Kuritzkes, Daniel R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 1931 - 1935
  • [6] Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors
    Chen, Wenwen
    Zhan, Peng
    De Clercq, Erik
    Liu, Xinyong
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (01) : 100 - 112
  • [7] Differential use of CCR5 by HIV-1 clinical isolates resistant to small molecule CCR5 inhibitors
    Henrich, T. J.
    Lewine, N.
    Lee, S-H
    Rao, S.
    Berro, R.
    Greaves, W.
    Gulick, R.
    Tsibris, A.
    Moore, J.
    Kuritzkes, D.
    ANTIVIRAL THERAPY, 2011, 16 : A59 - A59
  • [8] Interaction of small molecule inhibitors of HIV-1 entry with CCR5
    Seibert, Christoph
    Ying, Weiwen
    Gavrilov, Svetlana
    Tsamis, Fotini
    Kuhmann, Shawn E.
    Palani, Anandan
    Tagat, Jayaram R.
    Clader, John W.
    McCombie, Stuart W.
    Baroudy, Bahige M.
    Smith, Steven O.
    Dragic, Tatjana
    Moore, John P.
    Sakmar, Thomas P.
    VIROLOGY, 2006, 349 (01) : 41 - 54
  • [9] Recent Advances on Small-Molecule Survivin Inhibitors
    Xiao, Min
    Li, Wei
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (09) : 1136 - 1146
  • [10] Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase
    Choi, Eungi
    Mallareddy, Jayapal Reddy
    Lu, Dai
    Kolluru, Srikanth
    FUTURE SCIENCE OA, 2018, 4 (09):
12345